June 2, 2026 · Form 4 insider transaction
Heffernan Michael Thomas bought 29,500 shares of Avalo Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The stock option vests 100% on the first anniversary of the date of grant, subject to the director's continued service on such vesting date.